The influence of occupational exposure to PAHs on the blood plasma levels of p53 and p21WAF1 proteins

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 535, Issue 1, 2003, Pages 87-94

  Rössner Jr , Pavel ^a   Binková, Blanka ^a   Šrám, Radim J ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Coke oven workers; Plasma levels of p21WAF1 protein; Plasma levels of p53 protein; Polycyclic aromatic hydrocarbons

Indexed keywords

CARCINOGEN; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN; PROTEIN ANTIBODY; PROTEIN P21; PROTEIN P53;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; GENE IDENTIFICATION; GENE MUTATION; HUMAN; IN VITRO STUDY; INDUSTRIAL WORKER; MACHINE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; STRATIFICATION; WILD TYPE;

ADULT; BIOLOGICAL MARKERS; CARCINOGENS; CASE-CONTROL STUDIES; COKE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYCYCLIC HYDROCARBONS, AROMATIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037419749     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(02)00287-5     Document Type: Article

References (28)

1. Costantino J.P., Redmond C.K., Bearden A. Occupational related cancer risk among coke-oven workers: 30 years of follow-up. J. Occup. Med. 37:1995;597-604.
2. Kure E.H., Andreassen A., Ovrebo S., Grzybowska E., Fiala Z., Strozyk M., Chorazy M., Haugen A. Benzo[a]pyrene-albumin adducts in humans exposed to polycylic aromatic hydrocarbons in an industrial area of Poland. Occup. Environ. Med. 54:1997;662-666.
3. 32P -postlabelling Mutat. Res. 416:1998;67-84.
4. van Delft J.H., Steenwinkel M.S., van Asten J.G., de Vogel N., Bruijntjes-Rozier T.C., Schouten T., Cramers P., Maas L., van Herwijnen M.H., van Schooten F., Hopmans P.M. Biological monitoring the exposure to polycyclic aromatic hydrocarbons of coke-oven workers in relation to smoking and genetic polymorphisms for GSTM1 and GSTT1. Ann. Occup. Hyg. 45:2001;395-408.
5. Teixeira J.P., Gaspar J., Martinho G., Silva S., Rodrigues S., Mayan O., Martin E., Farmer P.B., Rueff J. Aromatic DNA adduct levels in coke-oven workers: correlation with polymorphism in genes GSTP1, GSTM1, GSTT1 and CYP1A1. Mutat. Res. 517:2002;147-155.
6. Buchet J.P., Ferreira M. Jr., Burrion J.B., Leroy T., Kirsch-Volders M., Van Hummelen P., Jacques J., Cupers L., Delavignette J.P., Lauwerys R. Tumor markers in serum, polyamines and modified nucleosides in urine, and cytogenetic aberrations in lymphocytes of workers exposed to polycyclic aromatic hydrocarbons. Am. J. Ind. Med. 27:1995;523-543.
7. Hatjian B.A., Edwards J.W., Harrison J., Williams F.M., Blain P.G. Ambient and biological effect monitoring of exposure to polycyclic aromatic hydrocarbons (PAHs). Toxicol. Lett. 77:1995;271-279.
8. Forni A., Guanti G., Bukvic N., Ferri G., Foa V. Cytogenetic studies in coke-oven workers. Toxicol. Lett. 88:1996;185-189.
9. Kalina I., Brezáni P., Gajdošová D., Binková B., Šalagovič J., Habalová V., Mračková G., Dobiáš L., Šrám R.J. Cytogenetic monitoring in coke-oven workers. Mutat. Res. 417:1998;9-17.
10. Janus F., Albrechtsen N., Dornreiter I., Wiesmuller L., Grosse F., Deppert W. The dual role model for p53 in maintaining genomic integrity. Cell. Mol. Life Sci. 55:1999;12-27.
11. 1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
12. WAF1 proteins and cell cycle distribution. Mutat. Res. 471:2000;57-70.
13. Mahadevan B., Luch A., Seidel A., Pelling J.C., Baird W.M. Effects of the (-)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene on DNA adduct formation and cell cycle arrest in human diploid fibroblasts. Carcinogenesis. 22:2001;161-169.
14. Brandt-Rauf P.W., Pincus M.R. Molecular markers of carcinogenesis. Pharmacol. Ther. 77:1998;135-148.
15. Charuruks N., Tangkijvanich P., Voravud N., Chatsantikul R., Theamboonlers A., Poovorawan Y. Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients. J. Gastroenterol. 36:2001;830-836.
16. Hanaoka T., Yamano Y., Katsuno N., Kagawa J., Ishizu S. Elavated serum levels of pantropic p53 proteins in chromium workers. Scan. J. Work Environ. Health. 23:1997;37-40.
17. Schneider J., Presek P., Braun A., Woitowitz H.J. Serum levels of pantropic p53 protein and EGF-receptor, and detection of anti-p53 antibodies in former uranium miners (SDAG Wismut). Am. J. Ind. Med. 36:1999;602-609.
18. Krajewska B., Lutz W., Pilacik B. Determination of blood serum oncoprotein NEU and antioncoprotein p53 - molecular biomarkers in various types of occupational exposure. Int. J. Occup. Med. Environ. Health. 11:1998;343-348.
19. Pan G., Hanaoka T., Yamano Y., Hara K., Ichiba M., Wang Y., Zhang J., Feng Y., Shujuan Z., Guan D., Gao G., Liu N., Takahashi K. A study of multiple biomarkers in coke-oven workers - a cross-sectional study in China. Carcinogenesis. 19:1998;1963-1968.
20. Luo J.C., Liu H.T., Cheng T.J., Du C.L., Wang J.D. Plasma p53 protein and anti-p53 antibody expression in vinyl chloride monomer workers in Taiwan. J. Occup. Environ. Med. 41:1999;521-526.
21. WAF1 protein levels in the blood plasma of occupationally exposed workers and in vitro in human diploid lung fibroblasts. Mutat. Res. 517:2002;239-250.
22. Rössner P., Bavorova H., Ocadlikova D. Biological monitoring of the environmental genotoxic effects - standard methods (in Czech). Acta Hyg. Epidemiol. Microbiol. 20:1989;3-15.
23. Watts R., Lewtas J., Stevens R., Hartlage T., Pinto J., Williams R., Hataway K., Míšková I., Beneš I., Kotěšovec F., Šrám R. Czech-US EPA health study. Assessment of personal and ambient exposures to PAH and organic mutagens in the Teplice district of northern Bohemia. Int. J. Environ. Anal. Chem. 56:1994;271-287.
24. EPA Report, Methods for determination of toxic organic compounds in ambient air, No. 600/4-84-041, EPA, NC, 1984.
25. Langone J.J., van Vunakis H. Radioimmunoassay of nicotine, cotinine and (3-pyridyl)-oxo-N-methylbutyramide. Methods Enzymol. 84:1982;628-640.
26. Stierum R.H., van Herwijnen M.H.M., Pasman P.C., Hageman G.J., Kleinjans J.C.S., van Agen B. Inhibition of poly(ADP-ribose) polymerase increases (±)-anti-benzo[a]pyrene diolepoxide-induced micronuclei formation and p53 accumulation in isolated human peripheral blood lymphocytes. Carcinogenesis. 16:1995;2765-2771.
27. Yang J., Duerksen-Hughes P. A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage. Carcinogenesis. 19:1998;1117-1125.
28. Rämet M., Castrén K., Järvinen K., Pekkala K., Turpeenniemi-Hujanen T., Soini Y., Pääkkö P., Vähäkangas K. p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis. 16:1995;2117-2124.